ABSTRACT
INTRODUCTIONpressures). The area under the curve (AUC) over the entire experimental period was calculated 140
for each blood pressure parameter. 141 142
Six-minute walk test 143
The purpose of this session was to determine the severity of the walking impairment as 144 assessed by the six-minute walk test (44). After 30 min of quiet rest in the semi recumbent 145 position, participants were asked to perform two bouts of 6-min of walking in a corridor, 146 separated by 10 min of rest between each bout. Participants received standardized instructions by 147 the investigators following the guidelines from the American Thoracic Society (33) and were 148 asked to achieve the greatest distance possible. Blood pressure, core temperature, HR and 149 perceived pain in the leg (Borg scale) were measured before and immediately after each test. 150
151

Phase-contrast MRI 152
The purpose of this protocol was to determine the magnitude and temporal profile of 153 changes in blood flow through the popliteal artery in the most symptomatic leg during 90 min of 154 TT application using phase-contrast MRI. MRI scanning was performed on a Siemens 3 Tesla 155 (T) Magnetom Prisma scanner (Siemens AG Healthcare Sector, Erlangen, Germany). Upon 156 arriving at the imaging facility, patients were asked to put on the water-circulating garment andgradient-echo technique was employed using the following acquisition parameters: TR 36.4 ms, 163 
Measurement of circulating inflammatory and vasoactive factors 172
Venous blood samples were collected in serum-separating tubes (BD Vacutainer SST 173 plus), allowed to clot for 30 min at room temperature, centrifuged for 15 min at 1200 rpms, 174 aliquoted and stored at -80ºC until analysis. The concentrations of endothelin-1 (ET-1), soluble 175 vascular cell adhesion molecule-1 (sVCAM-1) and soluble intercellular adhesion molecule 1 176 (sICAM-1) were determined using enzyme-linked immunosorbent assay (ELISA) kits (R&D 177 Systems, Minneapolis, MN) according to manufacturer's instructions. Quantification of total 178 nitric oxide (NOx) was performed using a commercial kit based on the Griess reaction (Total 179
Nitric Oxide Parameter Assay Kit, R&D Systems, Minneapolis, MN). A custom Milliplex ® assay 180 kit (EMD Millipore Corp, Billerica, MA) was used to determine the concentrations of several 181 angiogenic and inflammatory mediators, including: interleukin 6 (IL-6), interleukin 8 (IL-8), 182 interleukin 10 (IL-10), interleukin-1 receptor antagonist (IL-1Ra), interleukin 1 beta (IL1B), 183 tumor necrosis factor alpha (TNF-α), soluble tumor necrosis factor receptor 1 (sTNFR1), soluble 184 tumor necrosis factor receptor 2 (sTNFR2), chemokine (C-C motif) ligand 2 (CCL2) andvascular endothelial growth factor (VEGF). The assay was performed following the 186 manufacturer's protocol using the Bio-Plex 200 System (Bio-Rad, CA) at Indiana University's 187 fixed effect was found, pairwise differences were identified using the Bonferroni post hoc 196 procedure. The AUC for blood pressure was compared between trials using a paired Student t 197 test. Percent changes from baseline for average blood flow velocity, peak velocity and average 198 flow in the popliteal artery were calculated for each subject. A one-way repeated-measures (with 199 fixed time effect and random individual effect) ANOVA model was used to identify significant 200 changes in these parameters from baseline and post-hoc analysis (Bonferroni) was performed 201 when appropriate. For all analyses, P ≤ 0.05 was considered statistically significant. 202
203
RESULTS: 204
Patient demographic and clinical characteristics are listed in Table 1 . Six patients were 205 current smokers and the remainder of patients had a history of smoking. All but 2 patients were 206 taking at least one antihypertensive medication and 12 patients were taking statins and 207 antiplatelet agents. Physiological responses to the 6-min walk tests are shown on The overall goal of this study was to determine the effect of an acute session of TT on 253 systemic and leg hemodynamics and on the levels of circulating inflammatory and vasoactivemediators in patients with symptomatic PAD. One novel feature and strength of our design is 255 that TT was applied using a water-circulating garment system that is amenable for home-based 256 treatment. The main findings were that a single 90 min session of TT in patients with PAD: 1) 257 markedly reduced BP not only during but also for nearly 2 hours after the treatment; 2) promoted 258 a ~60% reduction in the serum concentration of the vasoconstrictor and pro-inflammatory 259 peptide endothelin-1 30 min after the therapy compared to the control intervention; 3) elicited an 260 increase (~100%) in blood flow through the popliteal artery. 261
262
Effects of TT on blood pressure 263
Hypertension is a major risk factor for PAD and a significant contributor to 264 cardiovascular morbidity and mortality associated with this condition (13). It is estimated that 265 more than half of patients with PAD are hypertensive (34). Patients with PAD also have an 266
augmented BP response to walking (48), which has been shown to be an independent predictor 267 of all-cause mortality and adverse cerebrovascular and cardiac events (18). Not surprisingly, 268
antihypertensive therapy is one of the pillars of medical management of PAD and there is 269 growing evidence that intensive blood pressure lowering can result in a marked reduction in 270 cardiovascular events in this patient population (6). Here we report for the first time that 271 exposure to 90 min of TT induced a robust reduction in BP when compared to the control 272 intervention, with average net reductions in systolic BP, diastolic BP and MAP during the 273 intervention of 11, 6 and 8 mmHg, respectively. Of note, this effect was sustained during the first 274 two hours after the therapy, with systolic BP, diastolic BP and MAP being on average 12, 6 and 275 7 mmHg lower than in the control condition. The magnitude of this acute hypotensive effect is 276 relevant and comparable to that achieved with well-established antihypertensive therapies in thispatient population. For example, we recently reported that ingestion of two doses of 50 mg (30 278 min apart) of the vasodilator sildenafil induced an average reduction of brachial systolic BP of 279 ~15 mmHg in patients with PAD (56). Cucato and co-workers showed that a 60-min session of 280 intermittent walking in patients with PAD reduced systolic BP, diastolic BP and MAP by 13, 5 281 and 7 mm Hg, respectively (15). Although it is unclear whether the observed acute hypotensive 282 response to TT would be sustained after regular treatment, evidence derived from exercise 283 studies suggests that the response to a single session is predictive of long-term reductions in BP 284 
Effects of TT on leg blood flow 292
Leg heating to a level sufficient to induce an increase in core body temperature of ~0.5-293 1ºC has been shown to enhance blood flow through the common and superficial femoral arteries 294 by 3-5 fold in healthy young individuals (11, 12, 53) . This heat-induced hyperemia is the result 295 of increases in blood flow not only to the skin but also to skeletal muscle as elegantly shown by 296
Heinonen and co-workers (27) and several others (11, 12, 53) . In the present study, we observed 297 that blood flow through the popliteal artery increased by ~2 fold, attaining peak levels at ~80 min 298 after the onset of the treatment (Figure 4) . Based on the aforementioned changes in femoral 299 blood flow in healthy young individuals (~3-5 fold) exposed to a similar thermal challenge (11, 12, 53) , it is evident that the hyperemic response to TT is impaired in patients with PAD. This is 301 expected given that vasodilator function of conduit and resistance vessels in the leg is known to 302 be severely compromised in these patients (38). Nonetheless, it is conceivable that repeated 303 increases in blood flow and the consequent increases in wall shear-stress during treatment with 304 TT can enhance peripheral vascular reactivity in patients with PAD. This notion is supported by 305 several observations in healthy young subjects as well as in different patient populations. 306
Seminal studies by Green and co-workers revealed that repeated forearm heating for 8 weeks 307
induces a blood flow dependent increase in conduit artery and skin vasodilatory function in 308 healthy subjects (24, 49) . Similarly, treatment with far-infrared dry sauna has been shown to 309 enhance flow-mediated dilation of the brachial artery in patients with chronic heart failure (32, 310
52) and patients with atherogenic risk factors (28). Combined, this compelling evidence indicates 311
that TT may be a practical and effective strategy to improve peripheral vascular endothelial 312 function even in the presence of multiple comorbidities and risk factors for atherosclerosis. 313
314
Effects of TT on circulating ET-1 concentration 315
Increases in limb blood flow during thermal stress reflect the combined vasodilation of 316 the cutaneous and skeletal muscle circulations (14). The robust vasodilation of the cutaneous 317 vasculature in response to heat stress is mediated, among others, by neural components and local 318 production of vasodilators, such as nitric oxide (29). In skeletal muscle, the mechanistic basis of 319 heat-induced vasodilation is less defined, but emerging evidence indicates that ATP released by 320 erythrocytes play an important role (30). The observation of a reduction in circulating levels of 321 ET-1 following TT (Figure 3 ) is important, as this molecule is the most abundant vasoconstrictor 322 produced by the vascular endothelium (60). This peptide exerts is effects through the activation (58, 61) and skin blood flow (36) and results in marked reductions in BP in healthy subjects (58) . 328
The circulating concentration of ET-1 is known to be elevated in patients with atherosclerosis 329 (35), including those with PAD (17, 41), and pharmacological blockade of ET-1 receptors has 330 been consistently associated with improvements in blood flow and vasodilation in patients with 331 atherogenic risk factors (10, 51) and coronary and peripheral artery disease (3, 4). Based on this 332 extensive evidence, it is fair to speculate that the observed reduction in ET-1 concentration can 333 explain, at least in part, the increases in leg blood flow and the consequent reduction in BP 334 following exposure to TT in the present study (Figures 3 and 4) . 335
In addition to its potent vasoconstrictor effects, ET-1 is pro-inflammatory and mitogenic, 336 and is strongly linked to endothelial dysfunction and the progression of atherosclerosis (5, 54). 337
The levels of ET-1 are known to be an independent predictor of all-cause and cardiovascular 338 mortality in patients with severe PAD (50). Mangiafico and co-workers showed that the changes 339 in the concentration of this factor could be a marker of clinical improvement following therapies 340 such as prostaglandin (PG) E1 in PAD patients (40). Recently, De Haro and co-workers 341 documented that treatment with dual ET-receptor antagonist bosentan improved claudication 342 distance and vascular function in patients with PAD (16). Whether similar effects can be
Clinical implications 347
The prevalence of PAD is expected to rise drastically in the coming decades and a 348 pressing need remains for the development of a therapeutic strategy that is widely accessible and 349 economically viable to treat patients with this condition. Exercise training is undoubtedly the 350 most efficacious approach, but it is well known that only a very minor fraction of patients with 351 symptomatic PAD participates in exercise rehabilitation (2, 55). Studies that have investigated 352 the barriers behind the lack of adherence of these patients to physical activity programs have 353 consistently shown that leg pain during exercise and environmental barriers, such as the lack of 354 walkable areas, are among the top reasons (1, 21). Thermotherapy is an attractive tool in this 355 regard because it is painless and amenable for home-based application. We chose to apply the 356 therapy using a water-circulating garment coupled with a water pump because as opposed to 357 more traditional forms of TT, such as sauna, this set-up is portable and therefore patients do not 358 need to travel to a clinical facility frequently to receive the treatment. In addition, TT can be used 359 in patients with severe disease and limited locomotion for whom exercise therapy is not an 360
option. 361 362
Limitations 363
One limitation of the present study was that serum concentrations of inflammatory, 364 angiogenic and vasoactive factors were not corrected for the potential change in plasma volume 365 induced by sweating during the TT protocol. Although we did not measure body mass after the 366 interventions, it was evident that the heating protocol induced water loss and a potential 367 consequent reduction in plasma volume. This is important as the observed reduction in serum 368
ET-1 concentration after TT would likely be larger when accounting for this response. A secondlimitation is that blood samples were taken from the arm, which was not directly heated during 370 the TT protocol. It is conceivable that the responses of circulating factors to TT application 371 would be different if the measurements were made in samples of venous blood draining from the 372 heated legs. Lastly, it is important to point out that we focused solely on the recovery period after 373 the intervention (30 and 120 min after TT) and it is unclear whether the responses of blood 374 parameters measured at these time points are similar to the changes induced during the 375 intervention. Additional studies are needed to determine the temporal profile of changes in the 376 concentrations of serum cytokines and vasoactive mediators in response to TT in patients with 377
PAD. 378
An additional limitation of this study is that popliteal blood flow, as determined using 379 phase-contrast MRI, was not measured under a normothermic, control condition, in which 380 thermoneutral water is perfused through the garment for 90 min. However, prior studies in young 381 healthy individuals reported that circulating water at 33-34ºC through a tube-lined suit covering 382 the legs does not alter bulk leg blood flow and calf blood flow (27, 31). Also, popliteal blood 383 flow was not measured in the recovery period following the TT intervention in the present study. 384
Since tissue blood flow responses to heat stress are largely determined by local temperature 385 sensitive mechanisms (12), it is anticipated that leg blood flow would fall gradually toward 386 baseline levels after the therapy as observed for leg skin temperature (Figure 1, left panel) . 387
It is important to note that the fact that the participants wore the water-circulating 388 garment and polyvinyl chloride pants during the post-interventional period following TT likely 389 slowed the recovery kinetics of some physiological variables, including leg skin and core body 390 temperature, leg blood flow and blood pressure. Although the heated bath circulator was turned-391 off after 90 min of TT, the water contained inside the tube-lined garment was still warm in theearly recovery period. If the subjects had promptly removed the garment after 90 min of TT and 393 exposed the legs to room temperature, it is possible that the physiological responses during 394 recovery from TT would be different than observed in the present study. Future studies should 395 determine the optimal treatment duration and recovery strategy to maximize the beneficial 396 responses to this novel therapeutic approach. 397 398
Perspectives and significance 399
Overall, the findings from the present study indicate that TT has the potential to fulfill the 400 
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